| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 14.21 | -0.13 (-0.91%) | 12.50 - 16.99 | 85.1 thousand (Below Avg) |
Market data as of 4:03PM 05/21/13. Quotes are delayed by at least 15 min.
| Open | 14.31 |
|---|---|
| Previous Close | 14.34 |
| Day's Range | 14.13 - 14.39 |
| Market Cap | 513.3M |
| Avg Volume (10 Day) | 164.5K |
| Price/Earnings (Trailing 12 Mo.) | 23.1x |
| Earnings Per Share (Trailing 12 Mo.) | 0.62 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Pass |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Fail |
| Increased shareholder value? | Pass |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Neutral |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Neutral |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Neutral |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Pass |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
Emergent BioSolutions to Webcast Presentation at Jefferies 2013 Global Healthcare Conference
Business Wire - Monday 05/20/2013 7:00 AM ET
Emergent BioSolutions to Hold Annual Meeting of Stockholders Thursday May 23, 2013 at 9:00 AM Eastern; Webcast Will Be Available
Business Wire - Thursday 05/16/2013 7:00 AM ET
Emergent BioSolutions to Webcast Presentation at Bank of America Merrill Lynch 2013 Health Care Conference
Business Wire - Thursday 05/09/2013 7:00 AM ET
Emergent BioSolutions Presents Preclinical Efficacy Data on ES414 Its Lead ADAPTIR Bispecific Therapeutic for Prostate Cancer
Business Wire - Friday 05/03/2013 7:00 AM ET
Emergent BioSolutions Reports Financial Results for First Quarter 2013
Business Wire - Thursday 05/02/2013 4:01 PM ET
Emergent BioSolutions Participates in NATO Defense against Terrorism Workshop at the Counter Terror Expo in London
Business Wire - Tuesday 04/30/2013 1:03 PM ET
Emergent BioSolutions to Webcast Presentation at Credit Suisse First Annual Antibody Day
Business Wire - Monday 04/29/2013 7:00 AM ET
Emergent BioSolutions to Acquire Healthcare Protective Products Division of Bracco Diagnostics Inc.
Business Wire - Thursday 04/25/2013 7:00 AM ET
| EBS | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -9.99% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.14 | |
| LT Debt/Equity | 0.13 | |
| Earnings Yield | 4.33% | |
| Price/Sales | 1.89 |
| Company | Last | Change |
|---|---|---|
| Merrimack Pharmaceuticals Inc | 5.27 | -0.19% |
| Idenix Pharmaceuticals Inc | 4.07 | +0.25% |
| Protalix Biotherapeutics Inc | 5.21 | +0.19% |
| Spectrum Pharmaceuticals Inc | 8.13 | +0.98% |
| Sequenom Inc | 4.06 | -1.22% |
Data is delayed by at least 15 min.